Ebeling, P <br/><br/>
Concentration of the complement activation product, acylation-stimulating protein, is related to C-reactive protein in patients with type 2 diabetes.  [electronic resource] 

 -  Metabolism: clinical and experimental  Mar 2001 
 - 283-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0026-0495 
<br/><br/><label>Standard No.: </label>10.1053/meta.2001.21032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute-Phase Proteins--analysis<br/>Blood Glucose--analysis<br/>Blood Proteins--analysis<br/>C-Reactive Protein--analysis<br/>Complement Activation--physiology<br/>Complement C3--analysis<br/>Complement C3a--analogs & derivatives<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Female<br/>Glyburide--therapeutic use<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Osmolar Concentration<br/>Pioglitazone<br/>Thiazoles--therapeutic use<br/>Thiazolidinediones